Latest News & Features
Big Pharma
Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA. 6 September 2022
Big Pharma
CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid 6 September 2022
Americas
Massachusetts-based target company specialises in rare blood disorders | Deal gives Novo Nordisk access to lead development candidate, etavopivat. 2 September 2022
Americas
Lengthy opinion invalidated plaintiff’s patent but ruled that defendant’s would still infringe | Patents at issue related to treatment for high blood pressure in the lungs. 1 September 2022
Big Pharma
New partner brings pharma and chemistry focus, and boosts the European firm’s Unified Patent Court team. 1 September 2022
Americas
Suit claims a contractor used AltaThera secrets to launch a rival heart arrhythmia drug | Chicago-based company wants the court to add its founder as co-inventor on patent. 1 September 2022
article
O’Melveny has hired life sciences patent litigator Gregory Morris for its New York office as a partner in its IP and technology practice group. 30 August 2022
Generics
Pharma company facing lawsuit from two universities | Dispute centres on therapeutically effective co-crystals patent. 30 August 2022
Americas
Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine. 30 August 2022
Big Pharma
Teva’s petition relies on a “blatantly misleading” question, argues GSK | Case presents “no new issues” that haven’t already been decided. 25 August 2022